WISE WQLF SAYS: Thanks for the FYI Good News for CVSI. Year over year Quarterly Revenue Growth for CV Sciences was UP+Plus 9 Percent. Charlotte’s Web was DOWN -16.10 Percent. YCBD was DOWN -28.80 Percent. Your CBD Store and Medterra are private concerns. Good luck getting their Trie numbers. All in All, Who’s on first, second or third has no meaningful value, especially when CV Sciences is standing on Home Plate YQU Now Understand YQU Understand. Check out the Recent Management Effectiveness and Profitability for CVSI, CWBHF, and YCBD. The BEST RUN COMPANY in the long run is where Wise Long Term investors place their Smart Monies YQU Now Understand YQU Understand. CVSI has increased revenues Dramatically while the Rest have declined tremendously. Always a pleasure to educate the people who need to be in the Know YQU DO Understand YQU Understand. Have Mercy Have Partners Have Patience Have Faith Have CVSI Continuous Success WISE WQLF Ahooooooo
CVSI Income Statement Revenue (ttm) 16.07M Revenue Per Share (ttm) 0.10 Quarterly Revenue Growth (yoy) 9.00%
FYI- According to data from SPIN, via Natural Products Insider (NPI), in the year ending April 23, 2023, sales of supplements containing CBD as the primary functional ingredient in the US declined about 20% year over year (YOY) from about $54.5 million to roughly $44 million.Sep 22, 2023
Inflation seems to be taking a toll on CBD sales in the U.S., based on insights from global measurement and data analytics company NielsenIQ (NIQ). From March 2022 to March 2023, hemp-based CBD product sales declined by 10% nationwide.Sep 12, 2023
CWBHF Income Statement Revenue (ttm) 66.18M Revenue Per Share (ttm) 0.44 Quarterly Revenue Growth (yoy) -16.10%